Call Us + 33 1 84 88 31 00

Article R1243-3-1 of the French Public Health Code

I.-Establishments or organisations which apply for or are authorised to carry out activities involving the preservation and distribution of tissues and their derivatives in accordance with Article L. 1243-2 may also apply for authorisation to enter into agreements with the health establishments mentioned in the first paragraph of Article L. 1243-6, enabling the latter to ensure, on their premises, the storage and distribution of tissues or their derivatives intended for…

Read More »

Article R1243-4 of the French Public Health Code

I.-The application for authorisation provided for in Article L. 1243-2 shall be sent to the Director General of the Agence nationale de sécurité du médicament et des produits de santé by the legal entity requesting the authorisation, by any means that provides a date certain of receipt. This application specifies, for each establishment or organisation and, where applicable, for each of the sites of this establishment, the activities for which…

Read More »

Article R1243-5 of the French Public Health Code

A copy of the complete dossier is sent by the Director General of the Agence nationale de sécurité du médicament et des produits de santé to the Director General of the Agence de la biomédecine. The Director General of the Agence de la biomédecine sends his opinion to the Director General of the Agence nationale de sécurité du médicament et des produits de santé, within two months of the date…

Read More »

Article R1243-6 of the French Public Health Code

The Director General of the Agence nationale de sécurité du médicament et des produits de santé will notify the applicant of his decision within four months of the date on which the application is deemed to be complete. If the Director General considers that additional information is required to enable him to reach a decision on the application, he may suspend consideration of the application until the missing information has…

Read More »

Article R1243-7 of the French Public Health Code

I. – Substantial changes to the authorisation referred to in Article R. 1243-6 are subject to prior written authorisation by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, after obtaining the opinion of the Director General of the Agence de la biomédecine. Substantial changes are considered to be those relating to : 1° The types of activities and categories of tissues, derivatives,…

Read More »

Article R1243-8 of the French Public Health Code

Any changes relating to : 1° The name or administrative address of the establishment or organisation, or where applicable the authorised site; 2° The appointment of a new director of the establishment or authorised body or, in the case of the Etablissement Français du Sang, the appointment of a director of a blood transfusion establishment; 3° The implementation of new technical equipment, including new medico-technical software used for the traceability…

Read More »

Article R1243-10 of the French Public Health Code

The authorisations referred to in Article R. 1243-6 may be suspended or withdrawn in whole or in part, pursuant to Article L. 1245-1, and in particular in the event of danger to public health or the environment or breach of the rules of good practice provided for in Article L. 1245-6, by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, following a…

Read More »

Article R1243-11 of the French Public Health Code

Any establishment or organisation benefiting from the authorisation referred to in Article R. 1243-6 must have put in place agreements or procedures with another establishment or other establishments or organisations authorised under this same article, guaranteeing that in the event of interruption or cessation of activity, the tissues, their derivatives, the cells or the cell therapy preparations are transferred there. By way of derogation from the first paragraph, when the…

Read More »

Article R1243-12 of the French Public Health Code

Applicant establishments or organisations appoint a responsible person who ensures compliance with the regulations relating to the quality and safety of tissues or their derivatives or cell therapy preparations, as well as one or more interim responsible persons who, for the period of replacement, are entrusted with the same powers and duties as those conferred on the responsible person and effectively exercise them for the duration of the replacement. The…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.